Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05281471
What this trial is testing

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian CancerFallopian Tube Cancer+4 more
Genelux Corporation 186
Early research (Phase 1)Study completedNCT03667716
What this trial is testing

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Who this might be right for
Advanced CancerOvarian CancerBreast Cancer+7 more
Compugen Ltd 121
Not applicableUnknownNCT04176484
What this trial is testing

Feasibility of Opportunistic Salpingectomy During Non-Gynecologic Surgery

Who this might be right for
Ovarian Cancer
University of Virginia 150
Testing effectiveness (Phase 2)UnknownNCT06509971
What this trial is testing

QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
West China Second University Hospital 39
Large-scale testing (Phase 3)Study completedNCT04908787
What this trial is testing

A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 421
Not applicableUnknownNCT06238284
What this trial is testing

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+1 more
Chongqing University Cancer Hospital 300
Not applicableStudy completedNCT06613230
What this trial is testing

Improved Early Diagnosis in Female Pelvic Cancer With OC Detect

Who this might be right for
Ovarian CancerEndometrial CancerBreast Cancer+3 more
Region Skane 490
Not applicableLooking for participantsNCT06475261
What this trial is testing

Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Oxygen DeficiencyAcute Kidney InjuryOvarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Testing effectiveness (Phase 2)UnknownNCT04846842
What this trial is testing

Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Lee's Pharmaceutical Limited 46
Testing effectiveness (Phase 2)Study completedNCT02560337
What this trial is testing

Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.

Who this might be right for
Ovarian Cancer
Vejle Hospital 26
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Ended earlyNCT00091195
What this trial is testing

Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390995
What this trial is testing

TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors

Who this might be right for
Ovarian CancerSolid Tumors
Takeda 28
Testing effectiveness (Phase 2)Study completedNCT01617629
What this trial is testing

Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study

Who this might be right for
Epithelial Ovarian Cancer
Prima BioMed Ltd 9
Testing effectiveness (Phase 2)Looking for participantsNCT06799637
What this trial is testing

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

Who this might be right for
Advanced Solid TumorsPancreatic CarcinomaOvarian Cancer+1 more
Evopoint Biosciences Inc. 350
Early research (Phase 1)Looking for participantsNCT07304128
What this trial is testing

PLB-002 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Primelink BioTherapeitics(ShenZhen) Limited 100
Not applicableUnknownNCT03150992
What this trial is testing

EDMONd - Elemental Diet in Bowel Obstruction

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Disease+6 more
Royal Surrey County Hospital NHS Foundation Trust 34
Early research (Phase 1)Looking for participantsNCT05518253
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Weijia Fang, MD 30
Testing effectiveness (Phase 2)Ended earlyNCT01083537
What this trial is testing

Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer+1 more
University Health Network, Toronto 1
Early research (Phase 1)UnknownNCT01242072
What this trial is testing

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Who this might be right for
MalignancyCancerNon Small Cell Lung Cancer+5 more
Alaunos Therapeutics 12
Next Page